Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?
about
Molecular control of steady-state dendritic cell maturation and immune homeostasis.Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis.Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.Characterization of the recognition specificity of BH2, a monoclonal antibody prepared against the HLA-B27 heavy chain.Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis.Sulfasalazine Treatment Suppresses the Formation of HLA-B27 Heavy Chain Homodimer in Patients with Ankylosing Spondylitis.The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23.Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.Targeted Delivery of the HLA-B∗27-Binding Peptide into the Endoplasmic Reticulum Suppresses the IL-23/IL-17 Axis of Immune Cells in Spondylarthritis.
P2860
Q33882051-B0EDDE53-C221-4572-9E4F-7057FAA53FF2Q35025474-4AFA94E9-26B5-487B-B205-E4438ECFBC34Q35534758-73952031-7213-495D-8041-0AD4F28B8290Q35585625-19F3DCAC-40DE-432B-94AE-D73F5FFA0E10Q36164605-2CF775E7-92E3-42FA-B705-AE15321A1A83Q36512479-51E496C6-3354-4023-9DBB-E8C1EE1C952DQ37234677-E65439EC-E126-40A4-A4EE-3E754FCE5DB8Q38177340-37B1597C-F483-4581-97EF-2B3BCEF26614Q39185886-8BB4685F-97B6-4B5C-A6E5-230A3EC34B1FQ44177491-D3B7E131-BD31-4544-A765-B89AB90998F0Q49788544-0D66A45D-081E-4A2C-86A9-DB5AD007CFA5
P2860
Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress in spondylarthritis. ...... is: which cells drive disease?
@en
Progress in spondylarthritis. ...... is: which cells drive disease?
@nl
type
label
Progress in spondylarthritis. ...... is: which cells drive disease?
@en
Progress in spondylarthritis. ...... is: which cells drive disease?
@nl
prefLabel
Progress in spondylarthritis. ...... is: which cells drive disease?
@en
Progress in spondylarthritis. ...... is: which cells drive disease?
@nl
P2860
P921
P356
P1476
Progress in spondylarthritis. ...... is: which cells drive disease?
@en
P2093
Dirk Elewaut
Lode Melis
P2860
P2888
P356
10.1186/AR2722
P577
2009-06-25T00:00:00Z
P5875
P6179
1043020482